Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.

Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U.

GMS Health Technol Assess. 2010 Apr 27;6:Doc05. doi: 10.3205/hta000083.

3.

Discrimination analysis of mass spectrometry proteomics for cervical cancer detection.

Liu C, Pan C, Shen J, Wang H, Yong L, Zhang R.

Med Oncol. 2011 Dec;28 Suppl 1:S553-9. doi: 10.1007/s12032-010-9740-8. Epub 2010 Nov 16.

PMID:
21080108
4.

Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study.

Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, Mitsuhashi A, Fujii T, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H; Japan HPV And Cervical Cancer Study Group.

Int J Cancer. 2011 Jun 15;128(12):2898-910. doi: 10.1002/ijc.25630. Epub 2010 Oct 13.

5.
6.

The impact of obesity on gynecologic cancer screening: an integrative literature review.

Aldrich T, Hackley B.

J Midwifery Womens Health. 2010 Jul-Aug;55(4):344-56. doi: 10.1016/j.jmwh.2009.10.001. Review.

PMID:
20630361
7.

New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Guo R, Pan C, Shen J, Liu C.

J Cancer Res Clin Oncol. 2011 Mar;137(3):513-9. doi: 10.1007/s00432-010-0899-3. Epub 2010 May 21.

PMID:
20490864
8.

Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC.

Gynecol Oncol. 2010 Aug 1;118(2):116-22. doi: 10.1016/j.ygyno.2010.04.013. Epub 2010 May 21.

PMID:
20488510
9.

Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure.

Kang WD, Oh MJ, Kim SM, Nam JH, Park CS, Choi HS.

Am J Obstet Gynecol. 2010 Jul;203(1):72.e1-6. doi: 10.1016/j.ajog.2010.01.063. Epub 2010 Apr 24.

PMID:
20417477
10.
11.

Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States.

Forhan SE, Gottlieb SL, Sternberg MR, Xu F, Datta SD, McQuillan GM, Berman SM, Markowitz LE.

Pediatrics. 2009 Dec;124(6):1505-12. doi: 10.1542/peds.2009-0674. Epub 2009 Nov 23.

PMID:
19933728
12.

Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.

Pietrowska M, Marczak L, Polanska J, Behrendt K, Nowicka E, Walaszczyk A, Chmura A, Deja R, Stobiecki M, Polanski A, Tarnawski R, Widlak P.

J Transl Med. 2009 Jul 13;7:60. doi: 10.1186/1479-5876-7-60.

13.

Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.

Piyathilake CJ, Macaluso M, Alvarez RD, Bell WC, Heimburger DC, Partridge EE.

Cancer Prev Res (Phila). 2009 Jul;2(7):658-64. doi: 10.1158/1940-6207.CAPR-08-0175. Epub 2009 Jun 19. Erratum in: Cancer Prev Res (Phila Pa).2009 Sep;2(9):842.

14.

Plasma protein profiles differ between women diagnosed with cervical intraepithelial neoplasia (cin) 1 and 3.

Piyathilake CJ, Oelschlager DK, Meleth S, Partridge EE, Grizzle WE.

Cancer Inform. 2007 Feb 27;2:345-9.

15.

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ.

Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Review.

PMID:
18847555
16.

Cervical cancer incidence in a prevaccine era in the United States, 1998-2002.

Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):360-70. Erratum in: Obstet Gynecol. 2007 Apr;109(4):1002.

PMID:
17267837
17.
18.

Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.

Bosch FX, de Sanjosé S.

J Natl Cancer Inst Monogr. 2003;(31):3-13. Review.

PMID:
12807939
19.

Epidemiology of cancer of the cervix: global and national perspective.

Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K.

J Indian Med Assoc. 2000 Feb;98(2):49-52.

PMID:
11016150
20.

Human papillomavirus infection in women infected with the human immunodeficiency virus.

Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr.

N Engl J Med. 1997 Nov 6;337(19):1343-9.

Items per page

Supplemental Content

Write to the Help Desk